Thomas Martin Kuendig - 01 Oct 2025 Form 4 Insider Report for XBiotech Inc. (XBIT)

Role
Director
Signature
Thomas Kuendig
Issuer symbol
XBIT
Transactions as of
01 Oct 2025
Net transactions value
$0
Form type
4
Filing time
12 Nov 2025, 09:53:42 UTC
Previous filing
30 Sep 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kuendig Thomas Martin Director ALPENSTRASSE 23, 8803 RUESCHLIKON, KANTON OF ZUERICH, RUESCHLIKON, SWITZERLAND Thomas Kuendig 12 Nov 2025 0002088590

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XBIT Director Stock Option Award $0 +79,115 $0.000000 79,115 01 Oct 2025 Common Stock 79,115 $2.64 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

On October 1, 2025 (the Grant Date) the reporting person was granted nonstatutory stock options (the Options) under the Company's 2025 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in two equal portions at four month and ten month from the Grant Date with an expiry of ten years from the Grant Date.T